Clinical variables and infarct size in the Zwolle trial patients
| PCI (n = 194) | SK (n = 201) | p Value | |
|---|---|---|---|
| LDHQ72, enzymatic infarct size, LVEF, left ventricular ejection fraction; MI, myocardial infarction; PCI, percutaneous coronary intervention; SK, streptokinase. | |||
| Age >60 | 94 (48%) | 109 (54%) | 0.25 |
| Men | 160 (82%) | 158 (79%) | 0.37 |
| Hypertension | 36 (19%) | 40 (20%) | 0.73 |
| Anterior MI | 77 (40%) | 74 (34%) | 0.60 |
| Previous MI | 38 (20%) | 31 (15%) | 0.29 |
| Diabetes | 16 (8%) | 16 (8%) | 1.00 |
| Infarct size | |||
| LVEF (%) | 49.8 (10.3) | 44.9 (11.3) | <0.001 |
| LDHQ72 | 939 (738) | 1289 (1144) | <0.001 |